Long-lived enzymatic metabolites of thromboxane B2 in the human circulation.
暂无分享,去创建一个
G. FitzGerald | C. Patrono | J. Lawson | G. Ciabattoni | G. FitzGerald | Carlo Patrono | John A. Lawson | Giovanni Ciabattoni
[1] G. FitzGerald,et al. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo. , 1986, The Journal of clinical investigation.
[2] G. FitzGerald,et al. Estimated rate of thromboxane secretion into the circulation of normal humans. , 1986, The Journal of clinical investigation.
[3] G. FitzGerald,et al. Measurement of urinary 2,3-dinor-thromboxane B2 and thromboxane B2 using bonded-phase phenylboronic acid columns and capillary gas chromatography--negative-ion chemical ionization mass spectrometry. , 1985, Analytical biochemistry.
[4] G. Remuzzi,et al. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. , 1985, The Journal of clinical investigation.
[5] W. C. Still,et al. Synthesis and structure of the platelet aggregation factor thromboxane A2 , 1985, Nature.
[6] M. LeWinter,et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. , 1983, The New England journal of medicine.
[7] G. FitzGerald,et al. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. , 1983, Circulation.
[8] G. FitzGerald,et al. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. , 1983, The Journal of clinical investigation.
[9] E. Granström,et al. Profiles of prostaglandin metabolites in the human circulation. Identification of late-appearing, long-lived products. , 1982, Biochimica et biophysica acta.
[10] M. Inoue,et al. Elevation of Thromboxane B2 Levels in Patients with Classic and Variant Angina Pectoris , 1981, Circulation.
[11] L. Hillis,et al. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. , 1981, The New England journal of medicine.
[12] C. Patrono,et al. Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. , 1980, Thrombosis research.
[13] R. Hardy,et al. Controlled Trial of Aspirin in Cerebral Ischemia , 1977, Stroke.